Loading data for LABU — first visit, this takes a few seconds.
Direxion Daily S&P Biotec... (LABU)
NYSEArca: LABU
· Echtzeitkurs · USD
341.55
+51.57 (17.78%)
Zum Schluss: Aug 19, 2026, 8:00 PM
343.21
+0.49%
Nachbörslich: 7:30 PM
Direxion Daily S&P Biotech Bull 3X Shares (LABU) ETF Price, Holdings & Analysis
17.78% (1D)
Keine Daten verfügbar
| Geld | 328.94 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 494.37 Mio |
| NAV | 287.06 |
| Beta | 3.26 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | k.A. |
| Ausstehende Anteile | k.A. |
| Auflagedatum | May 28, 2015 |
| Brief | 330.33 |
| Volumen | 352,047 |
| Ø Vol. (20D) | 519,361 |
| Eröffnung | 318.50 |
| Vortagesschluss | 289.98 |
| Tagesspanne | 314.50 - 332.64 |
| 52-Wk Range | 65.82 - 333.00 |
| Positionen | k.A. |
| Kostenquote | 0.96% |
Über LABU
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Anlageklasse Equity
Tickersymbol LABU
Auflagedatum May 28, 2015
Anbieter Direxion Funds
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 3.23% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Apogee Therapeutics ... | APGE | 1.16% |
| Oruka Therapeutics I... | ORKA | 1.07% |
| Dianthus Therapeutic... | DNTH | 1.00% |
Dividenden Dividendenrendite 0.39%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 23, 2025 | $0.9100 | k.A. |
| Sep 23, 2025 | $0.1030 | k.A. |
| Jun 24, 2025 | $0.2190 | k.A. |
| Mar 25, 2025 | $0.1070 | k.A. |
| Jun 25, 2024 | $0.1500 | k.A. |